The Joint Corp.
The Joint Corp.
Your view on JYNT
Overview
What the company does, where it operates, and who runs it.
About The Joint Corp.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Sanjiv Razdan
- Headquarters
- 16767 North Perimeter Drive, Scottsdale, AZ, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Sanjiv Razdan
- Headquarters
- 16767 North Perimeter Drive, Scottsdale, AZ, US
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers.
As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for The Joint Corp., and the rating behind it. JYNT last traded at $7.85, 29.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for The Joint Corp.. Starting points for The Joint Corp.: P/E 29.5, EPS $0.27, beta 1.06 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for The Joint Corp.. The Joint Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for The Joint Corp.. Trailing twelve-month EPS for The Joint Corp. stands at $0.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for The Joint Corp.. The Joint Corp. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
The Joint Corp. valued side by side against its closest peers. The Joint Corp. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold The Joint Corp., and how their positions are changing. At a $111.9M market value, institutional positions materially move The Joint Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by The Joint Corp. executives and directors. Shares of The Joint Corp. have traded between $7.50 and $13.47 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming The Joint Corp.. The Joint Corp. is a $111.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming The Joint Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for The Joint Corp.. Coverage tracks The Joint Corp. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.